Company / FCF Margin
United Therapeutics FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
32.7%
FY2025
5-year range
28.3% / 37.5%
FY2021-FY2025
Trend
-12.9%
vs FY2024
Sector context
#12 of 134
Health Care
What the data says
Among 134 Health Care companies, United Therapeutics is in the top 9% for fcf margin. FCF Margin has fluctuated over the past 10 years, ranging from -20.0% in FY2019 to 46.9% in FY2020.
Based on SEC 10-K filings.
32.7% in FY2025 with a 5-year CAGR of -14.2%. Top quartile in the Health Care sector.
Remained stable around 32.7% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -1.6pp
- 5-Year Change
- -14.2pp
- 10-Year Change
- -
Sector benchmark
Top 9% in Health CareTop 9% of 134This company 32.7% Sector average -637.8%
▼
+105.1% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 12.9% year-over-year.
- Currently 670.5pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2020.
- Lowest fcf margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 32.7% | -12.9% |
| FY2024 | 37.5% | +16.9% |
| FY2023 | 32.1% | -6.3% |
| FY2022 | 34.3% | +21.0% |
| FY2021 | 28.3% | -39.7% |
| FY2020 | 46.9% | +334.3% |
| FY2019 | -20.0% | -154.9% |
| FY2018 | 36.5% | +60.6% |
| FY2017 | 22.7% | -40.0% |
| FY2016 | 37.9% | +66.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026